4//SEC Filing
Caladrius Biosciences, Inc. 4
Accession 0001144204-17-028452
$LSTACIK 0000320017operating
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:59 PM ET
Size
8.1 KB
Accession
0001144204-17-028452
Insider Transaction Report
Form 4
MYERS STEVEN S
Director
Transactions
- Award
Common Stock
2017-05-16+2,565→ 36,159 total
Holdings
- 8,434(indirect: By IRA)
Common Stock
- 1,954(indirect: By Trust)
Common Stock
- 802(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents an award of 2,565 Restricted Stock Units granted under the Issuer's 2015 Equity Compensation Plan that will vest on May 16, 2018. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.
- [F2]Includes 750 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on June 22, 2017, 1,650 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018, 2,565 shares of unvested Restricted Stock Units granted under the Issuer's 2015 Equity Compensation Plan that will vest on May 16, 2018 and 312 shares of unvested restricted stock granted under the Issuer's 2009 Equity Compensation Plan that will vest quarterly through June 2, 2018.
Documents
Issuer
Caladrius Biosciences, Inc.
CIK 0000320017
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000320017
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:59 PM ET
- Size
- 8.1 KB